What is the role of neuromuscular blocking drugs in ambulatory anesthesia?

Thomas W Cutter1

  • 1University of Chicago, Chicago, Illinois 60637, USA. tcutter@airway.uchicago.edu

Abstract

Insights

Muscle relaxants in ambulatory anesthesia should be used cautiously due to potential risks and impact on efficiency. Alternatives and judicious use of short-acting agents are recommended for better patient outcomes and operating room flow.

Area of Science:

  • Anesthesiology
  • Surgical Safety
  • Pharmacology

Background:

  • Muscle relaxants are commonly used in anesthesia.
  • Their use in ambulatory settings requires careful consideration due to potential side effects and impact on efficiency.

Purpose of the Study:

  • To review the judicious use of muscle relaxants in ambulatory anesthesia.
  • To discuss the impact of muscle relaxants on operating room efficiency, morbidity, and mortality.

Main Methods:

  • Review of current literature on muscle relaxant use in ambulatory anesthesia.
  • Analysis of adverse effects and impact on operating room efficiency.
  • Exploration of alternative anesthetic techniques.

Main Results:

  • Short-acting or low-dose muscle relaxants may be appropriate but are not always necessary.
  • Adverse effects range from mild to life-threatening, and even benign effects can cause delays.
  • Alternative techniques like opioids, propofol, topical anesthesia, laryngeal mask airway, regional anesthesia, or monitored anesthesia care can be effective.

Conclusions:

  • The use of muscle relaxants should be based on specific anesthetic and surgical needs.
  • Alternatives to muscle relaxants should be considered in ambulatory anesthesia.
  • Newer agents may offer improved profiles for muscle relaxation in ambulatory settings.

Related Concept Videos

Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions01:27

Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions

Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action01:17

Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action

Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...
Neuromuscular Junction And Blockade01:29

Neuromuscular Junction And Blockade

The site of chemical communication between a motor neuron and a muscle fiber is called the neuromuscular junction (NMJ). The end of the motor neuron at the NMJ divides into a cluster of synaptic end bulbs. The cytoplasm of these bulbs consists of synaptic vesicles enclosing acetylcholine molecules, the principal neurotransmitter released at the NMJ. The region opposite the synaptic bulb that ends in the muscle fiber is called the motor end plate, which has acetylcholine receptors. Within the...
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics01:11

Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics

All neuromuscular blocking agents are injected intravenously because they are poorly absorbed from the GI tract. Rapid onset is achieved with intravenous administration, although absorption is also adequate from an intramuscular injection. Since these agents are highly ionized, they do not readily penetrate cell membranes or cross the blood-brain barrier.
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
Classification of Skeletal Muscle Relaxants01:28

Classification of Skeletal Muscle Relaxants

Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...